Development of an open-source data analysis platform for high throughput screening in drug discovery and its application to E3 ligase IDOL inhibitor discovery project
<p>Alzheimer’s disease (AD) and cardiovascular diseases (CVDs) pose a major challenge in the coming decades considering an increasingly ageing population and demographic changes. MYLIP, also known as inducible degrader of the LDL receptor (IDOL) is an E3 ligase that is involved in the downregu...
Main Author: | Christott, T |
---|---|
Other Authors: | Christianson, J |
Format: | Thesis |
Language: | English |
Published: |
2024
|
Subjects: |
Similar Items
-
A multifunctional cross-validation high-throughput screening protocol enabling the discovery of new SHP2 inhibitors
by: Yihui Song, et al.
Published: (2021-03-01) -
Phenotypic screening approaches to develop Aurora kinase inhibitors: Drug Discovery perspectives
by: Carlos eMarugán, et al.
Published: (2016-01-01) -
HIGH THROUGHPUT SCREENING : METHODS, TECHNIQUES AND APPLICATIONS /
by: Wigglesworth, Mark J., editor, et al.
Published: (2020) -
Discovery of E3 Ligase Ligands for Target Protein Degradation
by: Jaeseok Lee, et al.
Published: (2022-10-01) -
The E3 ubiquitin ligase IDOL regulates synaptic ApoER2 levels and is important for plasticity and learning
by: Jie Gao, et al.
Published: (2017-09-01)